Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127384031 | 12738403 | 1 | I | 20160714 | 20160907 | 20160913 | 20160913 | PER | US-PFIZER INC-2016423430 | PFIZER | 28.00 | YR | M | Y | 54.42000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127384031 | 12738403 | 1 | PS | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | UNK | U | 19839 | FILM-COATED TABLET | ||||||||
| 127384031 | 12738403 | 2 | SS | VIVITROL | NALTREXONE | 1 | Intramuscular | 380 MG, MONTHLY (QMO) | 0 | 380 | MG | INJECTION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127384031 | 12738403 | 2 | Drug dependence |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127384031 | 12738403 | Dysarthria | |
| 127384031 | 12738403 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127384031 | 12738403 | 1 | 20160712 | 0 | ||
| 127384031 | 12738403 | 2 | 20160714 | 0 |